Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-05-024216
Filing Date
2005-04-29
Accepted
2005-04-29 09:24:05
Documents
1
Period of Report
2005-03-10

Document Format Files

Seq Description Document Type Size
1 rrd77005.html 4/A  
1 rrd77005.xml 4/A 4552
  Complete submission text file 0001181431-05-024216.txt   6297
Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Issuer) CIK: 0001012270 (see all company filings)

EIN.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COLLAGENEX PHARMACEUTICALS INC 41 UNIVERSITY DR STE 200 NEWTOWN PA 18940
Business Address
PFEIFFER DAVID F (Reporting) CIK: 0001233934 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-28308 | Film No.: 05782796